Krewel Meuselbach

What Krewel Meuselbach does

Krewel Meuselbach GmbH is a German pharmaceutical manufacturer founded in 1996 through the merger of Krewel Werke GmbH (Eitorf) and Meuselbach-Pharma GmbH (Thuringia), combining two companies with pharmaceutical traditions dating back to 1893 and 1745 respectively. The company specializes in phytopharmaceuticals (plant-based medicines) and operates from two GMP-certified production sites in Germany: Eitorf in North Rhine-Westphalia (headquarters and production) and Ilmenau/Gehren in Thuringia (production and export coordination). Its product portfolio spans both prescription drugs (Tramagit for pain, Opipram for anxiety, Morphin-HCl Krewel sustained-release morphine, Syneudon, Citalon, Ergo-Kranit for migraine, Mareen) and OTC products (Hedelix cough remedies and Valocordin-Doxylamin sleep aid), distributed through pharmacy channels in Germany and 50+ international markets.

The company's underlying technology platform centers on galenic product development with particular expertise in retard (extended-release) tablet formulations that enable once-daily dosing, and patented know-how in plant-based rapid-release preparations. Krewel Meuselbach is also working to establish new industry standards for active ingredient release in phytopharmaceuticals, addressing gaps where existing quality standards cover only drug-extract ratios and extraction solvents. Manufacturing capabilities include liquid pharmaceutical production in batches from 500 to 3,000 liters, tablet coating for 80-250 kg batches, blister and liquid packaging lines, and full EU Falsified Medicines Directive serialization and aggregation compliance through WIPOTEC-OCS, Mettler Toledo Garvens, and Arvato CSDB systems.

The business operates two revenue streams: branded pharmaceutical product sales (Rx and OTC) through pharmacy distribution networks in Germany, plus own sales organizations in Russia and Slovakia and partner channels covering 50+ countries; and contract manufacturing services (Lohnherstellung) for third-party pharmaceutical companies seeking GMP-certified capacity for liquids, tablets, serialization, and packaging. The company holds EU-GMP, Russia GMP, Ukraine GMP, and Libya GMP certifications supporting its international operations. It is a family-owned private GmbH with 101-250 employees, emphasizing its identity as a traditional German 'Mittelstand' pharmaceutical company focused on plant-based medicines and exclusively German production.

Name

Krewel Meuselbach

Legal name

Krewel Meuselbach GmbH

Website

https://krewelmeuselbach.de

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

101–250 employees

Short description

Krewel Meuselbach GmbH is a German family-owned pharmaceutical manufacturer specializing in plant-based medicines (Rx and OTC), operating two GMP-certified production sites and serving pharmacy channels in Germany plus 50+ international markets through own sales organizations and distribution partners.

Ownership category

akta.pro rank

Product category

Phytopharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cold, Flu & Cough Remedies (HLAIADAB)

akta.pro secondary industries

Sleep, Stress & Mood Support (HLAIADAG), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Herbal pharmaceutical manufacturing
• Phytopharmaceutical products
• Contract pharmaceutical manufacturing
• Prescription and OTC medicines
• GMP certified manufacturing

Headquarters

HQ city

Eitorf

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales (Rx and OTC): Revenue from manufacturing and selling proprietary branded pharmaceutical products including prescription (rezeptpflichtige) products such as Tramagit, Opipram, Morphin-HCl Krewel, Syneudon, Citalon, Ergo-Kranit, Mareen, and over-the-counter products such as Hedelix (cough remedy) and Valocordin-Doxylamin (sleep aid). Products are sold through pharmacy channels.
2. Contract Manufacturing (Lohnherstellung): Third-party pharmaceutical companies engage KrewelMeuselbach as a contract manufacturer (Lohnhersteller) for liquid pharmaceutical forms (Oralia, solutions, drops) and tablets/film tablets. Services include product transfer, serialization, packaging, and distribution support.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Krewel Meuselbach GmbH is a German pharmaceutical manufacturer specializing in phytopharmaceutical (plant-based) medicines, producing both prescription (Rx) and over-the-counter (OTC) products for indications including cough/cold, pain, migraine, anxiety, depression, and sleep disorders. The company also offers B2B contract manufacturing (Lohnherstellung) of liquid pharmaceutical forms and tablets, including serialization, packaging, and GMP-compliant warehousing services for external pharmaceutical clients.

Product overview

Krewel Meuselbach GmbH is a German pharmaceutical manufacturer specializing in both OTC and prescription medications. The product portfolio includes the OTC brand Hedelix® (Hedelix® Hustensaft, Hedelix® s.a. Tropfen, Hedelix® Husten-Brausetabletten) containing ivy leaf extract for cough relief, and Valocordin®-Doxylamin for sleep disorders. Prescription products include Tramagit® (pain management), Opipram® (anxiety disorders), Morphin-HCl Krewel® (sustained-release morphine), Syneudon®, Citalon®, Ergo-Kranit® (migraine), and Mareen® (50 mg and 100 mg). The company also offers contract manufacturing services (Lohnherstellung) for liquids (Liquida) and tablets, serialization services, GMP-compliant warehousing, and international distribution support.

Differentiator

Problem solved

Functional benefit

Brands

• Hedelix®: Herbal cough remedy product line containing ivy leaf extract, available as syrup, drops, and effervescent tablets.
• Valocordin®

Products and services

• Hedelix Hustensaft OTC herbal cough syrup containing ivy leaf extract (Auszug aus Efeublättern). Alcohol-free, sugar-free, dye-free, suitable for infants. Available in 100 ml (N1) and 200 ml (N2) pack sizes. Sold through pharmacies.
• Hedelix s.a. Tropfen OTC herbal cough drops containing ivy leaf extract. Suitable from age 2 and older. Available in 20 ml (N1) and 50 ml (N2) pack sizes. Sold through pharmacies.
• Hedelix Husten-Brausetabletten OTC herbal cough effervescent tablets containing ivy leaf dry extract (Efeublättertrockenextrakt), blackcurrant flavor, suitable as hot/cold drink. Pack size: 20 tablets (N1). Cost-effective herbal alternative to ACC effervescent tablets.
• Valocordin-Doxylamin Lösung OTC sleep aid solution containing doxylamine for treating occasional sleep disorders (onset and maintenance insomnia) in adults. Available in pharmacies (apothekenpflichtig).
• Tramagit Prescription pain medication available as 100 mg/ml oral solution, 100/150/200 mg sustained-release (retard) tablets, and standard tablets for pain management.
• Opipram Prescription medication available as 50 mg and 100 mg film-coated tablets for the treatment of anxiety and somatoform disorders.
• Morphin-HCl Krewel Prescription sustained-release morphine tablets available in 10 mg, 30 mg, 60 mg, 100 mg, and 200 mg doses for pain management.
• Syneudon Prescription medication available as 50 mg tablets.
• Citalon Prescription medication available as 20 mg and 40 mg film-coated tablets (Citalon 20 mg Filmtabletten, Citalon 40 mg Filmtabletten).
• Ergo-Kranit Prescription migraine tablets for the treatment of migraine.
• Mareen Prescription medication available as 50 mg tablets and 100 mg film-coated tablets.
• Contract Manufacturing (Lohnherstellung) B2B contract manufacturing service for liquid pharmaceutical forms (Liquida - Oralia, solutions, drops) and tablets/film tablets. Includes product transfer, serialization (EU Falsified Medicines Directive), packaging, warehousing (5,000 pallet spaces across two GMP-compliant sites), and international distribution support. Batch sizes up to 3,000 liters for liquids; tablet coating from 80 to 250 kg. Targets pharmaceutical companies seeking GMP-certified manufacturing partners.

Quantifiable outcome

• 100% verification rate during serialization code application
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• European Pharmaceutical Companies (unnamed)coreStrategic or Co-development PartnerCooperation with well-known pharmaceutical companies from Germany and Europe who utilize KrewelMeuselbach's manufacturing know-how and galenic technologies. These partnerships extend the reach of the company's technologies and expertise to patients in countries not directly served by KrewelMeuselbach.
• Rhein-Sieg-Werkstätten (Lebenshilfe Eitorf)minorOthersLong-term social partnership with Rhein-Sieg-Werkstätten, a sheltered workshop for people with disabilities. Since 1987, a garden group from this facility has maintained the company grounds. Demonstrates the company's social responsibility commitment.
• German Association of Pharmaceutical Manufacturers (BAH-Bonn)minorOthersMember of the Bundesverband der Arzneimittel-Hersteller e.V. (BAH), the German Association of Pharmaceutical Manufacturers based in Bonn.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Dr. Willmar Schwabe GmbH & Co. KG: One of the world's leading manufacturers of phytopharmaceuticals (e.g., Tebonin, Umckaloabo). Closely comparable as a German herbal-medicine specialist with deep galenic research capabilities and international distribution, competing for the same OTC and Rx phytopharmaceutical shelf space.
• Bionorica SE: German phytopharmaceutical manufacturer headquartered in Neumarkt, focusing on plant-based medicines (e.g., Sinupret, Imupret). Directly comparable as a German Mittelstand herbal-medicine specialist with pharmacy-channel distribution and similar therapeutic-area focus (respiratory, immune).
• Klosterfrau Melissengeist (CMK GmbH): Cologne-based German OTC specialist in herbal remedies (Melissengeist, Klosterfrau Arnika). Comparable as a heritage German herbal/OTC manufacturer with pharmacy-channel distribution and overlapping respiratory/sleep/wellness categories.
• Hermes Arzneimittel GmbH: German OTC pharmaceutical manufacturer specializing in mineral salts, electrolyte products, and consumer health brands. Comparable as a German Mittelstand pharma manufacturer with own brands and contract-manufacturing services targeting pharmacy channels.
• Pohl-Boskamp GmbH & Co. KG: German specialty pharmaceutical manufacturer focused on niche Rx and OTC products (e.g., GeloRevoice, Nitrolingual). Comparable as a family-owned German Mittelstand pharma with similar scale, specialty positioning, and pharmacy-channel focus.
• Biologische Heilmittel Heel GmbH: German manufacturer of combination herbal and bioregulatory medicines, headquartered in Baden-Baden. Comparable as a German herbal/homeopathic specialist with international distribution and a focus on natural-source therapeutic products distributed through pharmacy channels.
• Aenova Holding GmbH: Leading European pharmaceutical CDMO offering contract development and manufacturing of solid, semi-solid, and liquid dosage forms. Comparable specifically with Krewel Meuselbach's Lohnherstellung business — same customer base of pharma companies outsourcing manufacturing plus packaging/serialization.
• G. Pohl-Boskamp / Rottapharm | Madaus: Madaus (now part of Rottapharm|Meda) is a German herbal pharmaceutical manufacturer known for brands like Myrrhinil-Intest and Cystinol. Comparable as a heritage German phytopharmaceutical specialist competing in the same herbal OTC and Rx pharmacy channels.

Broad incumbents

• Dermapharm Holding SE: German pharmaceutical company combining branded pharma, generics, and parallel imports. Comparable as a German Mittelstand pharma with diversified portfolio including OTC and Rx products distributed via German pharmacy channels, though at a larger scale.
• STADA Arzneimittel AG: Large German generics and OTC company with broad European footprint. Comparable as a German-headquartered pharma with extensive consumer-health/OTC portfolio and contract manufacturing services, though operating at materially larger scale and broader scope than Krewel Meuselbach.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/krewel-meuselbach-gmbh

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Krewel Meuselbach